opendata.bot
Company number
02907620

VERTEX PHARMACEUTICALS (EUROPE) LIMITED

Active
✓ Active company on the official register. Next accounts due 30 September 2026.

Company details

London, England Contains OS data © Crown copyright and database right. Contains Royal Mail data © Royal Mail copyright and database right. Source: Office for National Statistics licensed under the Open Government Licence v.3.0.
Registered name
VERTEX PHARMACEUTICALS (EUROPE) LIMITED
Company number
02907620
Registered office
2 KINGDOM STREET, LONDON, W2 6BD, ENGLAND · 749 other companies at this postcode
Company type
Private Limited Company
Incorporated on
11 March 1994
Status
Active
Age
32 years
Nature of business (SIC)
72190 — Other research and experimental development on natural sciences and engineering
Accounts — next due
30 Sept 2026
Accounts — last made up to
31 Dec 2024
Confirmation statement — next due
25 Mar 2027
Confirmation statement — last
11 Mar 2026

Gender pay gap

What this employer reported to the government. The figure is the difference in median hourly pay as a share of men's — so a positive number means men are paid more, and a negative one means women are.

9.4% median gap in 2025 · women are 48% of the best-paid quarter

201821.0%
201933.3%
202028.5%
202121.2%
202220.0%
202315.2%
202415.9%
20259.4%

Narrowed by 11.6 points since 2018. Each year is what the employer filed for that year, not a restatement.

Published by every UK employer with 250 or more staff. Compare employers →

People with significant control

Beneficial owners holding over 25% of shares, voting rights or the right to appoint directors

Vertex Pharmaceuticals Incorporated
owns 75–100% of shares · holds 75–100% of voting rights · can appoint and remove directors
Notified 06/04/2016
Vertex Pharmaceuticals Uk Holdings Limited
owns 75–100% of shares · holds 75–100% of voting rights · can appoint and remove directors
Notified 31/12/2024

Corporate structure

Who controls this company, and who they control in turn

2 controllers Drag to move · scroll to zoom · double-click to expand
Company Person Current control Ended

Connections

Corporate owner owns 75–100% of shares · holds 75–100% of votes · can appoint and remove directors Notified 31/12/2024
Vertex Pharmaceuticals Incorporated name only
owns 75–100% of shares · holds 75–100% of votes · can appoint and remove directors Control ended 31/12/2024 Controls 2 companies

Change history

Reconstructed from the dated records Companies House publishes

DateChangeWasNow
31/12/2024 Person with significant control ceased Vertex Pharmaceuticals Incorporated
31/12/2024 Person with significant control added Vertex Pharmaceuticals Uk Holdings Limited
06/04/2016 Person with significant control added Vertex Pharmaceuticals Incorporated

Documents for VERTEX PHARMACEUTICALS (EUROPE) LIMITED

Need this one company on file? Buy the document on its own — no plan required.

Company extract£1.99

The full registration record as held today — name, number, status, registered office, company type, previous names, officers, PSC and SIC codes, timestamped for your file.

PDF Order
Financial statements£3.99

Every figure the company’s own accounts state, across each filed period, with year-on-year movement. Most UK companies file small or micro-entity accounts — a balance sheet and a headcount, no turnover or profit.

PDF + CSV Order
Ownership report£3.99

Who controls the company: persons with significant control, the nature of that control, the ownership graph and every other company those controllers hold.

PDF Order

Data protection register

Registered with the Information Commissioner's Office as a data protection fee payer.

Vertex Pharmaceuticals (Europe) Ltd — W2 6BD
Tier 3 · renews 19/12/2026
ICO entry

The ICO publishes no company number, so this is matched on the registered name and confirmed by the postcode. Check the ICO entry before relying on it.

Get this company via API

Every field on this page is available as structured JSON behind one endpoint and one API key.

GET /v1/company/gb/02907620
X-Api-Key: $OPENDATA_KEY
Read the API docs

Frequently asked questions

What is the company number of VERTEX PHARMACEUTICALS (EUROPE) LIMITED?
According to the official registry, the company number of VERTEX PHARMACEUTICALS (EUROPE) LIMITED is 02907620.
Where is VERTEX PHARMACEUTICALS (EUROPE) LIMITED registered?
The registered office is 2 KINGDOM STREET, LONDON, W2 6BD, ENGLAND.
What is the SIC code of VERTEX PHARMACEUTICALS (EUROPE) LIMITED?
The nature of business is recorded under SIC code 72190 — Other research and experimental development on natural sciences and engineering.
Who controls VERTEX PHARMACEUTICALS (EUROPE) LIMITED?
Vertex Pharmaceuticals Incorporated is recorded as a person with significant control, and owns 75–100% of shares, holds 75–100% of voting rights, can appoint and remove directors.
When are the next accounts of VERTEX PHARMACEUTICALS (EUROPE) LIMITED due?
The next annual accounts are due by 30 September 2026, and the last accounts were made up to 31 December 2024.

About VERTEX PHARMACEUTICALS (EUROPE) LIMITED (02907620)

VERTEX PHARMACEUTICALS (EUROPE) LIMITED is a private limited company incorporated on 11 March 1994 and registered in the United Kingdom under company number 02907620. Its registered office is at 2 KINGDOM STREET, LONDON, W2 6BD, ENGLAND. The recorded nature of business is other research and experimental development on natural sciences and engineering (SIC 72190). The company is currently active , with statutory accounts last made up to 31 December 2024. , and the person with significant control is Vertex Pharmaceuticals Incorporated. This profile is provided by opendata.bot by Noetikos, aggregating official data from Companies House bulk data , last refreshed 2 September 2026.

Companies at the same registered office

Other research and experimental development on natural sciences and engineering across UK registers

The same sector and the same company, seen through every register we hold

Explore by sector

Every UK company records what it does as a SIC code — browse the sectors around this one.